First National Advisers’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$364K Sell
2,097
-492
-19% -$101K 0.05% 191
2025
Q4
$663K Sell
2,589
-220
-8% -$57.7K 0.09% 146
2025
Q3
$731K Buy
2,809
+104
+4% +$27.3K 0.1% 150
2025
Q2
$661K Sell
2,705
-759
-22% -$189K 0.1% 153
2025
Q1
$917K Buy
3,464
+749
+28% +$203K 0.15% 136
2024
Q4
$689K Sell
2,715
-1,048
-28% -$281K 0.11% 136
2024
Q3
$1.19M Buy
3,763
+154
+4% +$54.8K 0.19% 128
2024
Q2
$1.35M Sell
3,609
-877
-20% -$296K 0.25% 115
2024
Q1
$1.85M Sell
4,486
-880
-16% -$334K 0.41% 80
2023
Q4
$2.46M Buy
5,366
+1,709
+47% +$842K 0.71% 47
2023
Q3
$1.78M Buy
3,657
+1,524
+71% +$716K 0.79% 33
2023
Q2
$954K Sell
2,133
-8
-0.4% -$4.03K 0.88% 36
2023
Q1
$1.04M Buy
2,141
+134
+7% +$66.2K 1.18% 25
2022
Q4
$1.03M Buy
2,007
+217
+12% +$114K 1.32% 22
2022
Q3
$869K Buy
1,790
+554
+45% +$269K 1.29% 18
2022
Q2
$579K Buy
+1,236
New +$550K 1.2% 28

Other funds holding HUM

First National Advisers's HUM Position: Q1 2026 in Review

First National Advisers reduced its Humana (HUM) stake by 19% in Q1 2026, selling an estimated $101K and leaving 2,097 shares worth $364K. The position accounts for 0.05% of the portfolio, ranked #191.

First National Advisers first reported a position in HUM in Q2 2022 and has held it in 16 quarters since. The position peaked at $2.46M in Q4 2023. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • First National Advisers held 2,097 shares of Humana worth $364K as of Q1 2026.
  • First National Advisers sold 492 Humana shares in Q1 2026, an estimated $101K.
  • Humana made up 0.05% of First National Advisers's portfolio in Q1 2026, its #191 holding.
  • First National Advisers first reported a position in Humana in Q2 2022 and has held it in 16 quarters since.
  • First National Advisers's Humana position peaked at $2.46M in Q4 2023.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on First National Advisers's 13F filing for Q1 2026, filed 8 May 2026.